Denosumab increases BMD more than zoledronic acid in women who were treated with bisphosphonates.
Many express a preference for weekly or monthly oral bisphosphonate regimens.
Oral bisphosphonates appear to lower the risk for subsequent fracture and mortality after fracture.
Patients with type 2 diabetes may be at higher risk for fracture than indicated by FRAX score.
Many older people unconcerned about or unaware of osteoporosis.
Asian women taking bisphosphonates may have a higher risk for atypical femur fracture than white women.
Treatment improved bone balance and reduced bone turnover.
The sclerostin inhibitor may increase bone strength at the spine and hip in postmenopausal women.
Treatment over 5 years appears to be safe and effective.
Variables included gender and age.
Selective oral cathepsin K inhibitor odanacatib improved bone density in older women with osteoporosis.
PTH (1-84) for 7 years is linked to reduced calcium and calcitriol supplementation.
Denosumab treatment for up to 10 years is linked to persistent reduction in bone turnover and increased BMD.
Higher doses of vitamin D may actually do more harm than good in elderly women.
Three or more cups per day may lower risk for fracture.
Fracture risk may be lower with bisphosphonates in women with diabetes.
Fracture risk may be significantly lower in postmenopausal women with abaloparatide vs. teriparatide or placebo.
While these may serve as predictors, bone mineral density may not.
Endocrinology Advisor Articles
- Diet Quality and Glycemic Control in Women With Gestational Diabetes
- Most Foods Containing Fructose Do Not Have Harmful Effect on Glycemic Control
- Effects of a Low-Carbohydrate Diet on Weight Loss Maintenance
- Sleep Quality in Women With Surgical vs Natural Menopause
- Unhealthy Lifestyle and Rotating Night Shifts Put Nurses at Higher Risk for T2D
- Hypothyroidism Treatment No Longer Available
- Obesity Subtype May Determine Outcomes After Bariatric Surgery
- Few Physicians Work in Practices That Use Telemedicine
- Skin Autofluorescence Predicts T2D, Heart Disease, Mortality
- ACC: Smoking Cessation Expert Decision Pathway Emphasizes Team-Based Support